Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension

Clinical trial NCT04128137 · UNKNOWN

Trial details

NCT number: NCT04128137
Sponsor: H.A.C. PHARMA
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Neurogenic Orthostatic Hypotension

Start date: 2020-07-09
Primary completion: 2024-06-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.